Bosulif 400 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DX25FVHUK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $11,816
Award facts
- Contract value 100% obligated
- $11,815.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Department's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Bosulif 400 mg tablets in a quantity of 30 units, with a firm fixed price ceiling value of $11,815.63 and ultimate completion date of August 29, 2025. This is a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare systems. The delivery order represents a child contract action issued under the company's broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen Drug Corp to supply a wide range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. This prime indefinite delivery vehicle encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard. The award of this delivery order for Bosulif, a targeted therapy medication, demonstrates AmerisourceBergen Drug Corp's continued role as a primary vendor for specialized pharmaceutical products within the federal defense medical supply chain.
Quick answers
Who was awarded contract SPE2DX25FVHUK?
SPE2DX25FVHUK was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 8, 2025.
How much is contract SPE2DX25FVHUK worth?
The government has obligated $11,816 on SPE2DX25FVHUK.
Is contract SPE2DX25FVHUK an order under another contract?
Yes. SPE2DX25FVHUK is a delivery order under SPE2DX15D1022, an indefinite delivery contract.
Was contract SPE2DX25FVHUK competed?
The extent of competition for SPE2DX25FVHUK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award